Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-27 @ 10:47 PM
Study NCT ID:
NCT01629160
Status:
COMPLETED
Last Update Posted:
2019-02-04
First Post:
2012-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ventricular Wall Motion Characterization
Sponsor:
Abbott Medical Devices
Organization:
Study Overview
Official Title:
Characterization of Normal and Abnormal Ventricular Wall Motion
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate feasibility of using new technologies to characterize ventricular wall motion in patients indicated for mapping and ablation procedures. Echo will be performed preoperatively and patients will receive a 1-month followup telephone call.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: